Navigation Links
Alexza to Present at the MDB Bright Lights Conference 2011
Date:5/6/2011

ped for the rapid treatment of agitation in schizophrenic or bipolar disorder patients.  Alexza has completed and announced positive results from both of its AZ-004 Phase 3 clinical trials and submitted the AZ-004 NDA in December 2009.  In October 2010, the Company received a Complete Response Letter, or CRL, from the FDA, regarding its NDA for AZ-004.  A CRL is issued by FDA's Center for Drug Evaluation and Research indicating that the NDA review cycle is complete and the application is not ready for approval in its present form.  The Company completed an end-of-review meeting with the FDA in late December 2010.

The Company believes it has a clear understanding of the issues outlined in the CRL, is developing and executing a plan to address these issues, and currently projects a resubmission of the AZ-004 NDA in July 2011.

For more information about Alexza, the Staccato technology or the Company's development programs, please visit www.alexza.com.

Safe Harbor Statement

The anticipated presentation will contain forward-looking statements that involve significant risks and uncertainties.  Any statement describing the Company's expectations or beliefs is a forward-looking statement, as defined in the Private Securities Litigation Reform Act of 1995, and should be considered an at-risk statement.  Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of developing and commercializing drugs, including the adequacy of the Company's capital to support the Company's current operations, the potential of the Company's planned AZ-004 NDA resubmission to adequately address the issues in the CRL, the eventual prospects that AZ-004 will be approved for marketing and the timing of the Company's resubmission of the AZ-004 NDA to the FDA.  The Company's forward-looking statements also involve assumptions tha
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
5. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
6. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
7. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
8. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
9. Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
10. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
11. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... LOS ANGELES , Sept. 1, 2015 /PRNewswire/ ... biopharmaceutical research and development company specializing in oncology, ... Chairman and Chief Executive Officer, and David ... Investor Relations, will present a corporate overview at ... spotlight the biotechnology and healthcare industries: the FBR ...
(Date:9/1/2015)... , Sept. 1, 2015 Pressure ... a leader in the development and sale of ... solutions to the worldwide life sciences industry, today ... that suggest the Company,s PCT Platform could play ... personalized/precision medicine.  This role is based on PCT,s ...
(Date:9/1/2015)... -- BerGenBio AS ("BerGenBio" or the "Company"), ... appointed Hilde Furberg and Dr Stener ... Directors, effective immediately. Hilde Furberg ... biotech and is currently Senior Vice President Rare Diseases ... was Vice President and General Manager of Nordic Benelux ...
Breaking Medicine Technology:CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 2CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 3CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 4New Scientific Publication Suggests Pressure BioSciences' PCT Platform Could Play Significant Role in Personalized/Precision Medicine 2New Scientific Publication Suggests Pressure BioSciences' PCT Platform Could Play Significant Role in Personalized/Precision Medicine 3New Scientific Publication Suggests Pressure BioSciences' PCT Platform Could Play Significant Role in Personalized/Precision Medicine 4New Scientific Publication Suggests Pressure BioSciences' PCT Platform Could Play Significant Role in Personalized/Precision Medicine 5BerGenBio Appoints Non-Executive Directors 2
... Oct. 24, 2011 PhotoMedex , Inc. (NASDAQ: ... including the XTRAC® excimer laser ( www.XTRACLaser.com ), is offering ... XTRAC psoriasis treatments for children, an underserved population of ... presented in recognition of World Psoriasis Day ...
... 24, 2011 HealthWarehouse.com, Inc. (OTC: HEWA), a ... it will begin providing prescription medications for WhiteGlove ... "We,re excited to have a national partner ... areas," said Robert Fabbio, co-founder and chief executive ...
Cached Medicine Technology:PhotoMedex Increases Access to Care for Children in Recognition of World Psoriasis Day, Oct. 29 2PhotoMedex Increases Access to Care for Children in Recognition of World Psoriasis Day, Oct. 29 3PhotoMedex Increases Access to Care for Children in Recognition of World Psoriasis Day, Oct. 29 4WhiteGlove Health Selects HealthWarehouse.com to Provide Prescription Medications to its Members Nationwide 2
(Date:9/1/2015)... Meadows, Ill. (PRWEB) , ... September 01, 2015 ... ... procedures done by members of the American Society for Dermatologic Surgery, according to ... , The 2015 ASDS Consumer Survey on Cosmetic Dermatologic Procedures – which reflects ...
(Date:9/1/2015)... ... September 01, 2015 , ... Virginia entrepreneur Marcella Ellis, ... strongly maintaining her firm’s success in the hair care and distribution industry through ... tour, Ellis will be providing “Look and learn” live demonstrations, as well as ...
(Date:9/1/2015)... , ... September 01, 2015 , ... The Jerry Segal ... The ACE Club and Green Valley Country Club in Lafayette Hill, PA. Over the ... more than $13.5 million for programs and services designed to support patients and their ...
(Date:9/1/2015)... ... September 01, 2015 , ... e-Spirit ... version 5.2 of the FirstSpirit Content Management System with new capabilities and enhancements ... version of FirstSpirit, companies will be well on their way to achieving digital ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... The ... and incurable disease, facioscapulohumeral muscular dystrophy (FSHD), will be the beneficiary of a collection ... same mission – to raise awareness of the FSH Society and further FSHD research. ...
Breaking Medicine News(10 mins):Health News:Survey: Consumers Prefer ASDS Members 2Health News:Survey: Consumers Prefer ASDS Members 3Health News:Beauty Entrepreneur creates hair extension smart machine and mobile app inspired by UBER technology 2Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 2Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 3Health News:e-Spirit boosts Corporate Content Cloud initiative with release of FirstSpirit 5.2 2Health News:e-Spirit boosts Corporate Content Cloud initiative with release of FirstSpirit 5.2 3Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 2Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 3
... May 25, 2011 The American Society for Radiation Oncology ... Bernard Cummings, MB, ChB, FASTRO, as the Society,s 2011 Gold ... this honor at the Awards Ceremony held during ASTRO,s 53rd ... Fla. The Gold Medal is the Society,s highest honor. It ...
... by Trinity College Dublin that aims to ... selected for grant funding of 6 million by the ... NILVAD*, comprising 18 European universities, hospitals and pharmaceutical companies, ... treatment of Alzheimer,s disease (AD). Trinity College ...
... 20, most people have reached skeletal maturity and do not grow ... in the body also stopped by age 20. But a ... Chapel Hill has found evidence that, even though you,re not getting ... advance in age from 20 years to 79 years. "I ...
... National Institute of Standards and Technology (NIST) has released ... manufacturers evaluate the composition of their products and assure ... the human health effects of this popular beverage and ... prepared as part of an ongoing collaboration with the ...
... , TUESDAY, May 24 (HealthDay News) -- Long known as ... heart failure, a new study suggests. Research tracking more ... found that those whose diets included more baked and broiled ... -- had a 30 percent lower risk of heart failure ...
... care doctors have long been on the front lines of ... in 10 office visits and primary care doctors prescribe more ... University of Michigan Health System have developed a new tool ... which a patient,s depression has improved. The issue, the ...
Cached Medicine News:Health News:Ang, Cummings to receive ASTRO Gold Medal 2Health News:Clinical trials for new Alzheimer's disease treatment to be awarded European Commission €6m funding 2Health News:Pelvic widening continues throughout a person's lifetime, UNC study 2Health News:Care for a spot of (green) tea? New NIST reference materials for popular diet supplement 2Health News:Cooked Right, Fish Can Help a Woman's Heart 2Health News:Cooked Right, Fish Can Help a Woman's Heart 3Health News:New tool aims to improve measurement of primary care depression outcomes 2
... Right Solution For Your Tracheostomy Care Needs, ... tray features the latest components for efficient ... control task. Designed by clinicians, these latex-free ... each patient and caregiver. All of our ...
... Right Solution For Your Tracheostomy Care Needs, ... tray features the latest components for efficient ... control task. Designed by clinicians, these latex-free ... each patient and caregiver. All of our ...
... alternate care facilities with a wide ... offer the finest in nursing convenience ... guidance of experienced nursing personnel, these ... is required for efficient and quick ...
... alternate care facilities with a wide ... offer the finest in nursing convenience ... guidance of experienced nursing personnel, these ... is required for efficient and quick ...
Medicine Products: